Product Image

D3 125 mcg + K2 100 mcg

SportsResearch
4.8
★ ★ ★ ★ ★
(25345 ratings)
Vitamin K 100 mcg
Product Image
Score81
Useful MK-7 is paired with high-dose D3 in a softgel. Duplicate D entries and vitamin D above the usual upper intake level require careful interpretation and oversight.
How scoring works
Quantity:60 Softgel(s) • (60 servings)
Goals:
Heart Health
Bone Health
General Health
Cardiovascular Support
Anti-Aging

Score 81

Useful MK-7 is paired with high-dose D3 in a softgel. Duplicate D entries and vitamin D above the usual upper intake level require careful interpretation and oversight.
How scoring works

Also available as

1 option
200.00mcg • 60 Softgel(s) servings K 100 mcg • 60 Softgel(s) • 120 servings $44.97 ($0.37 per serving)
$23.95($0.39 per serving)
Vitacost
$ 24.97
iHerb
$ 25.97
Amazon
$ 26.59
Walmart
$ 23.95
Report prices

Analysis

The formula appears to provide one 125 mcg D3 serving from the named VegaDELight source plus 100 mcg of MK-7. Those active forms are relevant to vitamin D status and vitamin K-dependent calcium handling.

Two vitamin D entries repeat the same amount and appear to describe the active and its source rather than a combined 250 mcg dose. Even when normalized to 125 mcg, the vitamin D amount is high for routine unsupervised use.

Softgel delivery provides a practical format for fat-soluble vitamins. The product fits a monitored high-dose D3 plan, while maintenance users should choose a lower-D3 option with cleaner label presentation.

Who is it for
  • Adults with a monitored high-dose vitamin D plan
  • People seeking MK-7 alongside D3
  • Users able to verify the normalized label dose
Best for
  • Clinician-guided high-dose D3 use
  • Combined D3 and MK-7 support
  • Softgel calcium-regulation nutrition

Pros

  • Uses cholecalciferol
  • Provides 100 mcg of MK-7
  • Offers softgel delivery
  • Combines complementary vitamin forms

Cons

  • Vitamin D exceeds the usual adult upper intake level
  • Duplicate D3 entries reduce clarity
  • Not suited to casual supplement stacking
  • Requires total vitamin D monitoring

Warnings

  • The normalized 125 mcg vitamin D amount exceeds the usual adult daily upper intake level, so total intake and blood levels should be clinically reviewed.
  • Vitamin K2 can oppose warfarin and related vitamin K antagonists.
  • Verify that the repeated D3 entries describe one dose rather than two before use.

Nutrient quality

86 Highest impact

Cholecalciferol and menaquinone-7 are well-regarded forms. Both vitamins are supplied in meaningful amounts for bone support.

Ingredient transparency

82 Highest impact

Every active ingredient has a specific amount. Inactive ingredients are not supplied.

Customer satisfaction

73 High impact

The supplied average indicates very strong aggregate satisfaction. No detailed experience reports are available to identify repeated complaints or confirm perceived benefits.

Value for money

82 Highest impact

The high-quality forms support reasonable value for the cost. Serving value appears moderate for a focused vitamin combination.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

Vitamin K2 as MK-7 provides a targeted 100 mcg amount for calcium regulation and arterial health. Vitamin D3 complements K2 by supporting calcium handling, although the D3 amount is high for routine use without checking total intake.

Softgel delivery suits these fat-soluble vitamins. Vitamin K can oppose warfarin-type anticoagulants, so intake should remain consistent under prescriber guidance.

Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
Bone Health
Bone Health
Impact
Highest effect
A Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

Vitamin D3 and MK-7 form a strong pair for calcium absorption and placement in bone. Human evidence supports both nutrient roles, although the formula does not supply the calcium or protein matrix itself.

The 100 mcg MK-7 amount is clinically aligned, while the 125 mcg vitamin D3 amount is substantial and best matched to individual need. The liquid softgel is practical, but its carrier oil is not identified. MK-7 can oppose warfarin, so users of that anticoagulant need consistent intake and prescriber-guided monitoring.

Study evidence
Vitamin K Supportive 78 studies
General Health
General Health
Impact
Highest effect
A+ Goal FitB Strength of SupportB CoverageA+ Formula Quality
Vitamin D · 125 mcgVitamin K · 100 mcg

Vitamin D3 and MK-7 work together to support calcium metabolism, bone maintenance, and related immune functions. The MK-7 amount is well targeted, but the vitamin D3 amount exceeds the usual adult daily upper intake level.

The pairing is highly coherent and gives strong depth to one foundational pathway. People using warfarin-type anticoagulants need consistent vitamin K intake, and prolonged use of the vitamin D amount may warrant calcium and vitamin D monitoring.

Study evidence
Vitamin D Supportive 115 studies
Vitamin K Supportive 34 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
B+ Goal FitA- Strength of SupportC+ CoverageA Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

MK-7 and vitamin D3 form a logical pair for activating calcium-regulating proteins and supporting vascular integrity. The 100 mcg K2 amount is meaningful, and the liquid softgel suits fat-soluble vitamins.

The 125 mcg vitamin D3 amount is high for routine maintenance and may be unnecessary without a documented need or monitoring. MK-7 can oppose warfarin-type anticoagulants, so stable intake and prescriber-directed anticoagulant management are important.

Study evidence
Vitamin D Mixed 170 studies
Vitamin K Supportive 40 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
B+ Goal FitA- Strength of SupportC CoverageA Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

MK-7 and vitamin D3 work together to support bone maintenance and calcium handling, which are relevant to aging. The liquid softgel provides a practical dose and a suitable format for fat-soluble vitamins.

The active amounts and forms are clear, although the MK-7 source and lipid carrier are not specified. The concentrated vitamin D3 may be unnecessary for people with adequate status, while MK-7 can interfere with stable warfarin dosing.

Study evidence
Vitamin K Supportive 27 studies

Ingredients

IngredientAmount per serving
Vitamin D3 (Cholecalciferol, VegaDELight)
 125 mcg
Vitamin K2 (Menaquinone-7)
 100 mcg
Adults 18–50 Vegan Vegetarian
Report overview
Vitamin K (Menaquinone-7) · 100 mcg OverallScore90
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The 100 mcg MK-7 dose is well aligned with effective vitamin K2 use and is paired with vitamin D3. The source is generic, and the liquid softgel does not identify a specific lipid carrier in the supplied details. A low serving cost makes the formulation highly efficient.

View ingredientView products
Loading alternative details
87 Performance

Vitamin K2 100 mcg

SR Sports Research
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Performance

Vitamin K2 MK-7 (Menaquinone-7) 90 mcg

Carlson
<p>The formula provides 90 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Performance

Vitamin K2 as MK-7 100 mcg

Healthy Origins
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
88 Budget

Vitamin K2 MK-7 100 mcg

Nutricost
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K (Menaquinone-7), making it a practical budget alternative to the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Budget

MK-7 Vitamin K-2 100 mcg

NOW
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Menaquinone-7), making it a practical budget alternative to the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
85 Budget

Vitamin K2 MenaQ7 100 mcg

AN Amazing Nutrition Amazing Formulas
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Natto), making it a practical budget alternative to the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamins D3 2500 IU (62.5 mcg) & K2 120 mcg

NaturesPlus
<p>The formula combines 120 mcg of Vitamin K2 (Menaquinone-7) and 62.50 mcg of Vitamin D3 (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Value

MK-7 Vitamin K-2 100 mcg

NOW
<p>The formula combines 100 mcg of Vitamin K-2 (Menaquinone-7) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamin K2 100 mcg + Vitamin D3 125 mcg

Nutricost
<p>The formula combines 100 mcg of Vitamin K (Menaquinone-7) and 125 mcg of Vitamin D (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K2 (Menaquinone-7), 125 mcg of Vitamin D3 (Cholecalciferol), and 125 mcg of Vitamin D3 (VegaDELight). The high vitamin D amount warrants attention to total intake, and vitamin K may interfere with warfarin-type anticoagulants.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Meta-analysis6,759 participants19 studies pooledBone Health forVitamin K
  3. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  4. Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.
    Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M · Journal of bone and mineral metabolism · 2018
    Randomized trial1,874 participantsBone Health forVitamin K
  5. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  6. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  7. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  8. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  9. Interventions to Attenuate Cardiovascular Calcification Progression: A Systematic Review of Randomized Clinical Trials.
    Murali S; Smith ER; Tiong MK; Tan SJ; Toussaint ND · Journal of the American Heart Association · 2024
    Systematic review9,901 participants49 studies pooledCardiovascular Support forVitamin K
  10. Intake of dietary phylloquinone and menaquinones and risk of stroke.
    Vissers LE; Dalmeijer GW; Boer JM; Monique Verschuren WM; van der Schouw YT; Beulens JW · Journal of the American Heart Association · 2014
    Cohort study35,476 participantsCardiovascular Support forVitamin K
  11. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M · Maturitas · 2014
    Cohort study577 participantsCardiovascular Support forVitamin K
  12. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  13. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  14. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  15. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  16. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  17. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  18. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  19. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  20. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support Heart Health forVitamin D
  21. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
    Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V · Journal of the American Society of Nephrology : JASN · 2017
    Randomized trial120 participantsCardiovascular Support forVitamin D
  22. Randomized, placebo-controlled, double-blind clinical trial on the contributions of vitamin D in the control of cardiovascular risk factors, depressive symptoms and suicide risk.
    Porto C; Petribu K; Barbosa N; Magalhães R; Lira C; Porto AB; Markman-Filho B; Lordsleem A; Calado E; Magalhães J; Sougey E; Silva T; Junio A; Bandeira F; Leão R · American heart journal plus : cardiology research and practice · 2025
    Randomized trial224 participantsCardiovascular Support forVitamin D
  23. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial.
    Raed A; Bhagatwala J; Zhu H; Pollock NK; Parikh SJ; Huang Y; Havens R; Kotak I; Guo DH; Dong Y · PloS one · 2017
    Randomized trial70 participantsCardiovascular Support forVitamin D
  24. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsCardiovascular Support Heart Health forVitamin D
  25. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  26. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  27. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C · The Cochrane database of systematic reviews · 2014
    Meta-analysis95,286 participants159 studies pooledGeneral Health forVitamin D
  28. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A · Neurogastroenterology and motility · 2018
    Randomized trial90 participantsGeneral Health forVitamin D
  29. The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS; Wong Z; Thiruchelvam K · Inflammopharmacology · 2024
    Meta-analysis2,495 participants19 studies pooledGeneral Health forVitamin D
  30. Vitamin D Status and Mortality: A Systematic Review of Observational Studies.
    Heath AK; Kim IY; Hodge AM; English DR; Muller DC · International journal of environmental research and public health · 2019
    Systematic review84 studies pooledGeneral Health forVitamin D
  31. Meta-analysis of long-term vitamin D supplementation on overall mortality.
    Zheng Y; Zhu J; Zhou M; Cui L; Yao W; Liu Y · PloS one · 2014
    Meta-analysis42 studies pooledGeneral Health forVitamin D
  32. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  33. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  34. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  35. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  36. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  37. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  38. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  39. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K